サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1773949

全ゲノムシーケンスの世界市場

Whole Genome Sequencing

出版日
ページ情報
英文 464 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
全ゲノムシーケンスの世界市場
出版日: 2025年07月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 464 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

全ゲノムシーケンスの世界市場は2030年までに58億米ドルに達する見込み

2024年に21億米ドルと推定される全ゲノムシーケンスの世界市場は、2024年から2030年にかけてCAGR 19.0％で成長し、2030年には58億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器は、CAGR16.6％を記録し、分析期間終了時には28億米ドルに達すると予測されます。消耗品セグメントの成長率は、分析期間中CAGR 22.1％と推定されます。

米国市場は5億6,030万米ドルと推定、中国はCAGR 25.3％で成長予測

米国の全ゲノムシーケンス市場は、2024年には5億6,030万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは25.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に15.4%と16.8%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR 15.8%で成長すると予測されています。

世界の全ゲノムシーケンス市場- 主要動向と促進要因のまとめ

なぜ全ゲノムシーケンスがゲノミクス分野を変革するのか？

全ゲノムシーケンス（WGS）は、個人の全遺伝子コードの包括的な分析を提供することで、遺伝子調査、診断、個別化医療に革命をもたらしました。特定の遺伝子に焦点を当てる標的シーケンス法とは異なり、WGSは生物内のすべてのDNA配列を調べることで、遺伝的変異、疾患リスク、進化形質に関するより深い洞察を可能にします。遺伝性疾患、希少疾患、がんの有病率の増加により、ヘルスケアプロバイダーがより正確で個別化された治療アプローチを求める中、臨床診断におけるWGSの需要が高まっています。さらに、ファーマコゲノミクスの分野では、WGSを活用して個人の遺伝的体質に基づいて薬剤処方を調整し、副作用を減らして治療効果を向上させています。農業、微生物学、法医学におけるゲノムデータの利用の拡大も、WGSの応用範囲を拡大しています。シーケンシングのコストが低下し続け、ゲノム解析のための計算ツールが改善されるにつれて、WGSは医学・科学研究の主流ツールになりつつあり、精密医療における画期的な進歩への道を開いています。

AIとクラウド・コンピューティングはどのように全ゲノムシーケンスを強化するのか？

人工知能（AI）とクラウドコンピューティングの統合により、全ゲノムシーケンスの効率性と拡張性が大幅に向上しました。AI主導のアルゴリズムは、膨大なゲノムデータセットの解析に使用され、より高い精度とスピードで疾患マーカーや遺伝的変異を特定しています。また、機械学習モデルは、遺伝子プロファイルに基づいて病気のリスクを予測し、パーソナライズされた治療計画を推奨するために応用されています。クラウドコンピューティングは、大規模なゲノムデータセットの保存と共有を容易にし、研究者やヘルスケアプロバイダーが異なる場所からリアルタイムで共同研究できるようにしました。さらに、安全なゲノムデータ管理のためにブロックチェーン技術が検討されており、プライバシーと遺伝子情報の倫理的利用が確保されています。高スループットシーケンスプラットフォームと自動化されたバイオインフォマティクスパイプラインの採用により、WGSのペースはさらに加速し、臨床と研究の両方の用途において、よりアクセスしやすく費用対効果の高いものとなっています。AIとビッグデータ解析が進化し続けるにつれて、医療とバイオテクノロジーに革命をもたらすWGSの可能性は拡大する一方です。

全ゲノムシーケンスの普及を阻む課題とは？

その変革の可能性にもかかわらず、全ゲノムシーケンスはコスト、データプライバシー、倫理的懸念に関する課題に直面しています。シーケンスコストは近年大幅に低下しているもの、特に低リソースのヘルスケア環境においては、広く臨床に採用されるための障壁となっています。大規模なゲノムデータの管理と解釈には、専門的な専門知識と高度な計算インフラが必要であり、小規模な研究機関やヘルスケアプロバイダーがアクセスできる範囲は限られています。また、ゲノム情報は非常にセンシティブであり、同意、データの所有権、悪用の可能性に関する倫理的問題が生じるため、データのプライバシーに関する懸念も大きな課題となります。さらに、ゲノム検査やデータ共有に関する規制の枠組みは地域によって異なるため、世界の標準化にはハードルがあります。これらの課題に対処するには、コスト削減戦略への継続的な投資、データセキュリティ対策の強化、技術革新と患者の権利やプライバシーのバランスをとる倫理的ガイドラインの開発が必要です。

全ゲノムシーケンス市場の成長を促進する要因は？

全ゲノムシーケンス市場の成長は、個別化医療に対する需要の増加、シーケンス技術の進歩、研究や診断におけるアプリケーションの拡大など、いくつかの要因によって牽引されています。プレシジョン・メディシン・イニシアチブの台頭により、臨床現場でのWGS導入が加速し、がん、遺伝性疾患、感染症に対する標的治療が可能になりました。次世代および第3世代シーケンシングなど、シーケンシングプラットフォームの継続的な改良により、精度、スピード、価格が向上し、WGSがより幅広い研究者や臨床医にとって利用しやすくなりました。さらに、消費者直接遺伝子検査の拡大が個人ゲノミクスへの関心を煽り、包括的な遺伝子解析の需要を促進しています。農業、バイオテクノロジー、マイクロバイオーム研究におけるWGSの統合により、市場機会はさらに多様化し、ゲノムシーケンスは科学的発見と技術革新のための重要なツールとして位置づけられています。世界のゲノム研究の取り組みが強化され、ヘルスケアがデータ主導の個別化治療アプローチに移行する中、WGS市場は医療とバイオテクノロジーの未来を形成し、大幅な成長を遂げる態勢が整っています。

セグメント

コンポーネント（装置、消耗品、サービス）、タイプ（大型全ゲノムシーケンス、小型全ゲノムシーケンス）、用途（ヒト全ゲノムシーケンス、植物全ゲノムシーケンス、動物全ゲノムシーケンス、微生物全ゲノムシーケンス）、最終用途（学術・研究機関、病院・クリニック、製薬・バイオテクノロジー企業、その他）

調査対象企業の例

  • Agilent Technologies, Inc.
  • BGI Genomics Co Ltd.
  • Complete Genomics
  • Element Biosciences
  • Eurofins Genomics Germany GmbH
  • GeneDx
  • GENEWIZ
  • Illumina, Inc.
  • Macrogen
  • Nebula Genomics

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革します。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP33357

Global Whole Genome Sequencing Market to Reach US$5.8 Billion by 2030

The global market for Whole Genome Sequencing estimated at US$2.1 Billion in the year 2024, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Consumables segment is estimated at 22.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$560.3 Million While China is Forecast to Grow at 25.3% CAGR

The Whole Genome Sequencing market in the U.S. is estimated at US$560.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 25.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 16.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.8% CAGR.

Global Whole Genome Sequencing Market - Key Trends & Drivers Summarized

Why Is Whole Genome Sequencing Transforming the Field of Genomics?

Whole genome sequencing (WGS) has revolutionized genetic research, diagnostics, and personalized medicine by providing a comprehensive analysis of an individual’s entire genetic code. Unlike targeted sequencing methods that focus on specific genes, WGS examines all DNA sequences in an organism, enabling deeper insights into genetic variations, disease risks, and evolutionary traits. The increasing prevalence of genetic disorders, rare diseases, and cancer has driven demand for WGS in clinical diagnostics, as healthcare providers seek more accurate and personalized treatment approaches. Additionally, the field of pharmacogenomics is leveraging WGS to tailor drug prescriptions based on an individual’s genetic makeup, reducing adverse reactions and improving therapeutic efficacy. The growing use of genomic data in agriculture, microbiology, and forensic science has also expanded the scope of WGS applications. As sequencing costs continue to decline and computational tools for genome analysis improve, WGS is becoming a mainstream tool in medical and scientific research, paving the way for groundbreaking advancements in precision medicine.

How Are AI and Cloud Computing Enhancing Whole Genome Sequencing?

The integration of artificial intelligence (AI) and cloud computing has significantly enhanced the efficiency and scalability of whole genome sequencing. AI-driven algorithms are being used to analyze vast genomic datasets, identifying disease markers and genetic variations with greater accuracy and speed. Machine learning models are also being applied to predict disease risks and recommend personalized treatment plans based on genetic profiles. Cloud computing has facilitated the storage and sharing of large genomic datasets, enabling researchers and healthcare providers to collaborate in real time from different locations. Additionally, blockchain technology is being explored for secure genomic data management, ensuring privacy and ethical use of genetic information. The adoption of high-throughput sequencing platforms and automated bioinformatics pipelines has further accelerated the pace of WGS, making it more accessible and cost-effective for both clinical and research applications. As AI and big data analytics continue to evolve, the potential of WGS in revolutionizing medicine and biotechnology will only expand.

What Challenges Are Hindering the Widespread Adoption of Whole Genome Sequencing?

Despite its transformative potential, whole genome sequencing faces challenges related to cost, data privacy, and ethical concerns. While sequencing costs have dropped significantly in recent years, they remain a barrier for widespread clinical adoption, particularly in low-resource healthcare settings. The management and interpretation of large-scale genomic data require specialized expertise and advanced computational infrastructure, limiting accessibility for smaller research institutions and healthcare providers. Data privacy concerns also pose a major challenge, as genomic information is highly sensitive and raises ethical questions regarding consent, data ownership, and potential misuse. Additionally, regulatory frameworks governing genomic testing and data sharing vary across regions, creating hurdles for global standardization. Addressing these challenges requires continued investment in cost-reduction strategies, enhanced data security measures, and the development of ethical guidelines that balance innovation with patient rights and privacy.

What Factors Are Driving the Growth of the Whole Genome Sequencing Market?

The growth in the whole genome sequencing market is driven by several factors, including increasing demand for personalized medicine, advancements in sequencing technologies, and expanding applications in research and diagnostics. The rise of precision medicine initiatives has accelerated WGS adoption in clinical settings, enabling targeted therapies for cancer, genetic disorders, and infectious diseases. Continuous improvements in sequencing platforms, such as next-generation and third-generation sequencing, have enhanced accuracy, speed, and affordability, making WGS more accessible to a broader range of researchers and clinicians. Additionally, the expansion of direct-to-consumer genetic testing has fueled interest in personal genomics, driving demand for comprehensive genetic analysis. The integration of WGS in agriculture, biotechnology, and microbiome research has further diversified market opportunities, positioning genome sequencing as a key tool for scientific discovery and innovation. As global genomic research efforts intensify and healthcare moves toward data-driven personalized treatment approaches, the WGS market is poised for substantial growth, shaping the future of medicine and biotechnology.

SCOPE OF STUDY:

The report analyzes the Whole Genome Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Instruments, Consumables, Services); Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing); Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing); End-Use (Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Agilent Technologies, Inc.
  • BGI Genomics Co Ltd.
  • Complete Genomics
  • Element Biosciences
  • Eurofins Genomics Germany GmbH
  • GeneDx
  • GENEWIZ
  • Illumina, Inc.
  • Macrogen
  • Nebula Genomics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Whole Genome Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • The Rising Demand for Personalized Medicine Drives Growth in Whole Genome Sequencing
    • Technological Advancements in Sequencing Platforms Propel the Growth of the Whole Genome Sequencing Market
    • Expanding Applications of Whole Genome Sequencing in Oncology Accelerate Market Adoption
    • Government Initiatives to Support Precision Medicine and Genomics Propel the Whole Genome Sequencing Market
    • Growing Awareness of the Benefits of Early Genetic Testing for Disease Prevention Strengthens the Business Case for Whole Genome Sequencing
    • Decreasing Costs of Genome Sequencing Technology Drives Wider Adoption in Healthcare and Research
    • Integration of Artificial Intelligence (AI) in Whole Genome Sequencing Enhances Data Interpretation and Increases Market Potential
    • The Expansion of Genomic Databases and Biobanks Spurs Demand for Whole Genome Sequencing Services
    • The Increasing Focus on Genetic Research for Rare Diseases Drives Growth in Whole Genome Sequencing Applications
    • Rising Popularity of Direct-to-Consumer Genetic Testing Services Accelerates Consumer Demand for Whole Genome Sequencing
    • The Growth of Health and Wellness Apps That Include Genetic Testing as a Service Expands Addressable Market Opportunity for Genome Sequencing
    • Regulatory Advancements and Streamlined Approval Processes for Genetic Testing Create Opportunities for Whole Genome Sequencing
    • The Integration of Whole Genome Sequencing into Routine Healthcare Services Generates Stronger Demand for Genomic Solutions
    • Collaborations Between Pharmaceutical Companies and Genomics Providers Foster Growth in Whole Genome Sequencing for Drug Development
    • The Rising Importance of Whole Genome Sequencing in Research Institutions and Academic Settings Accelerates Market Expansion
    • The Growing Utilization of Whole Genome Sequencing in Reproductive Health, Including Prenatal Screening, Strengthens Market Demand
    • The Advent of Single-Cell Genomics and Its Synergy with Whole Genome Sequencing Expands Applications in Precision Medicine
    • Increasing Investment in Genomic Startups and Research Initiatives Promotes Innovation in Whole Genome Sequencing Technologies
    • The Demand for Whole Genome Sequencing in Agriculture for Crop Improvement and Animal Breeding Fuels Market Growth
    • The Role of Whole Genome Sequencing in Infectious Disease Research, Including Pathogen Genomics, Spurs Demand for Sequencing Solutions
    • The Rise of Global Health Challenges and the Need for Rapid Genomic Data to Track Infectious Disease Evolution Drives Whole Genome Sequencing Adoption
    • Growing Partnerships Between Public and Private Healthcare Organizations to Facilitate Genomic Data Access Supports Market Growth
    • Increasing Availability of Data for Genomic Research Drives Further Investment and Innovation in Whole Genome Sequencing Technologies
    • Consumer Privacy Concerns and Ethical Issues Surrounding Whole Genome Sequencing Data Create Challenges for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Genome Sequencing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Large Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Large Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Large Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Small Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Small Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Small Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Human Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Human Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Human Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Plant Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Plant Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Plant Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Animal Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Animal Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Animal Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Microbial Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Microbial Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Microbial Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • JAPAN
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • CHINA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • EUROPE
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Whole Genome Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • FRANCE
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • GERMANY
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Whole Genome Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • INDIA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 218: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Whole Genome Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Whole Genome Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030
  • AFRICA
    • Whole Genome Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by Component - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Whole Genome Sequencing by Component - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Whole Genome Sequencing by Component - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Whole Genome Sequencing by End-Use - Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Whole Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Others for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Whole Genome Sequencing by Type - Large Whole Genome Sequencing and Small Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Whole Genome Sequencing by Type - Percentage Breakdown of Value Sales for Large Whole Genome Sequencing and Small Whole Genome Sequencing for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Whole Genome Sequencing by Application - Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Whole Genome Sequencing by Application - Percentage Breakdown of Value Sales for Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing for the Years 2015, 2025 & 2030

IV. COMPETITION